BPC157 5 mg + TB500 5 mg (10 mg total peptides)
This product contains 10 mg total of two synergistic peptides:
5 mg BPC-157
5 mg TB-500
This compound is intended for research use only and should be handled only by qualified professionals in appropriate research settings.
BPC157 & TB500 10 is a dual-peptide injectable research compound combining:
BPC-157
A pentadecapeptide derived from a protein found in the stomach, known in research for supporting tissue repair, angiogenesis, and anti-inflammatory responses.
TB-500 (Thymosin Beta-4 fragment)
A synthetic peptide related to the naturally occurring thymosin beta-4 protein, studied for its role in cell migration, tissue regeneration, and wound healing.
Muscle, tendon, and ligament recovery studies
Joint and connective tissue repair research
Anti-inflammatory research in damaged tissue
Soft tissue regeneration models
Post-injury mobility and flexibility studies
The combination of BPC-157 and TB-500 may provide synergistic regenerative effects in experimental settings.
Do not use if:
You are allergic to BPC-157, TB-500, or any excipients
You are pregnant or breastfeeding
You are not trained in peptide research handling or injection protocols
This product is not approved for medical or therapeutic use
Intended for research purposes only
Not for individuals under 18 years old
Consult a qualified professional if:
Injection site irritation occurs
You have a bleeding disorder
You are using other peptide compounds
Avoid combining with other peptides unless part of a structured research protocol.
Use only according to your research protocol or supervising professional instructions.
Subcutaneous injection.
Because the vial contains 10 mg total peptides (5 mg each), dosing will depend on dilution and research protocol.
Example research ranges often reported:
| Application Area | Suggested Dose | Frequency |
|---|---|---|
| Injury recovery | 0.5 – 1 mg | Daily |
| Joint or tendon inflammation | 0.5 – 0.75 mg | Daily |
| Gut / GI research | 0.25 – 0.5 mg | Daily |
| Post-surgical recovery research | 1 mg | Daily |
| General regeneration studies | 0.5 mg | 5× per week |
Injection sites:
Abdomen (5 cm away from navel)
Outer thigh
Upper arm
Rotate injection sites to avoid irritation.
Potential side effects reported in peptide research include:
Mild redness at injection site
Fatigue
Headache
Nausea
Temporary flushing
Allergic reactions
Increased localized vascularization
If serious reactions occur, discontinue use and consult a professional.
Store refrigerated 2°C – 8°C
Do not freeze
Protect from sunlight
Keep out of reach of children
Use within 6–8 weeks after reconstitution
Do not use if solution appears cloudy or discolored.